作者：
Victoria,Wang [1]
;
Milan S,Geybels [2]
;
Kristina M,Jordahl [3]
;
Travis,Gerke [2]
;
Anis,Hamid [4]
;
Kathryn L,Penney [5]
;
Sarah C,Markt [6]
;
Matthew,Freedman [5]
;
Mark,Pomerantz [7]
;
Gwo-Shu M,Lee [5]
;
Huma,Rana [6]
;
Daniela,Börnigen [8]
;
Timothy R,Rebbeck [8]
;
Curtis,Huttenhower [8]
;
Ros A,Eeles [8]
;
Janet L,Stanford [9]
;
Practical,Consortium [10]
;
Sonja I,Berndt [11]
;
Frank,Claessens [5]
;
Karina D,Sørensen [10]
;
Jong Y,Park [11]
;
Ana,Vega [12]
;
Nawaid,Usmani [13]
;
Lorelei,Mucci [2]
;
Christopher J,Sweeney [14]
作者单位：
Department of Biostatistics & Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
[1]
Division of Public Health Sciences, Fred Hutchison Cancer Research Center, Seattle, Washington, USA.
[2]
Department of Epidemiology, GROW School for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands.
[3]
Cancer Epidemiology, Moffitt Cancer Center, Tampa, Florida, USA.
[4]
Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
[5]
Department of Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, Ohio, USA.
[6]
Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
[7]
Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts, USA.
[8]
University Medical Center Hamburg-Eppendorf, Bioinformatics Core, Hamburg, Germany.
[9]
Department of Biostatistics, Harvard T.H. Chan School of Public Health, Harvard University, Boston, Massachusetts, USA.
[10]
The Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
[11]
Oncogenetics, Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
[12]
The Royal Marsden NHS Foundation Trust, London, UK.
[13]
Prostate Cancer Association Group to Investigate Cancer Associated Alterations in the Genome.
[14]
Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, Maryland, USA.
[15]
Molecular Endocrinology Laboratory, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium.
[16]
Department of Molecular Medicine, Aarhus University Hospital, Aarhus N, Denmark.
[17]
Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, Florida, USA.
[18]
Fundación Pública Galega Medicina Xenómica, Santiago de Compostela, Spain.
[19]
Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada.
[20]
DOI
10.1002/pros.24148
PMID
33956343
发布时间
2022-07-16
换一批
换一批
